为ASO/CRISPR-Cas9传递而设计的银河糖双响应纳米载体,以抑制HBV复制
Liuxian Chen1, Qin Huang2, Yongjie Liu1
1Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Chongqing Medical University, No. 1, Yixueyuan Road, Chongqing, 400016, China.
Advanced healthcare materials
|October 3, 2025
概括
一种新的纳米载体 (UACPG) 结合了CRISPR/Cas9和反感性寡核酸来向和降解乙型肝炎病毒 (HBV) cccDNA和pgRNA,为HBV感染提供了潜在的治疗方法.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 基因治疗 基因治疗
- 纳米医学是一种纳米医学.
背景情况:
- 乙型肝炎病毒 (HBV) 治愈受到持续的ccDNA的限制.
- 目前针对HBV的基因编辑策略面临着低效率和非目标效应等挑战.
研究的目的:
- 开发一种使用新型纳米载体的HBV组合基因编辑疗法.
- 为了提高CRISPR/Cas9和抗意义寡核酸 (ASOs) 的传递和有效性,用于HBV根除.
主要方法:
- 设计了一种向肝细胞的纳米载体 (UACPG),用于双刺激响应释放CRISPR/Cas9和ASOs.
- 结合CRISPR/Cas9用于ccDNA破坏,与ASO用于pgRNA降解.
- 在水力动态HBV感染小鼠模型中评估UACPG的疗效.
主要成果:
- UACPG实现了肝脏特异性输送和治疗有效载荷的受控释放.
- 组合疗法显著降低了HBV复制,病毒抗原和ccccDNA水平.
- 没有观察到显著的非目标效应,证明了该方法的安全性.
结论:
- 该UACPG纳米载体平台能够有效地,有针对性地提供HBV的基因编辑工具.
- 这种组合策略显示出作为一种创新的治疗方法来实现完全治愈HBV的承诺.
更多相关视频
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
10.3K
09:56Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins
Published on: October 31, 2025
385
相关概念视频
01:28CRISPR/Cas9 Genome Editing
1.7K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.7K
01:59CRISPR
57.5K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.5K